← All organizations

Cipher Pharmaceuticals Inc.

For profitWebsite ↗

Also known as: Cipher Pharmaceuticals Inc. | CIPHER PHARMS INC | Halodine LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Mar 4, 2022

Timeline

2000s

Jun 1, 2000
Cipher Pharmaceuticals Inc.— Founded

2010s

May 7, 2010
tramadol— NDA Secondary Org
Apr 13, 2015
innocutis— Acquired

Drugs by trial phase (5 distinct, 5 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

isotretinoin

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Acne Vulgaris

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

innocutis

Recent trials (8)

NCT05310734OfficialPhase 4Mar 4, 2022
NCT05310734Lead sponsorPhase 4Mar 4, 2022
NCT04517188Lead sponsorPhase 4Oct 15, 2020
NCT04517188Study directorPhase 4Oct 15, 2020
NCT02307864CollaboratorPhase 1Dec 1, 2014
NCT01947920CollaboratorPhase 1Aug 1, 2013
NCT00975143Study directorPhase 3Sep 1, 2009
NCT00975143Lead sponsorPhase 3Sep 1, 2009

Details

Founded: Mississauga, ON, CA Jun 1, 2000
Last known activity: Mar 4, 2022